Universe Pharmaceuticals (UPC) Inventory Average (2021 - 2025)

Universe Pharmaceuticals has disclosed Inventory Average across 5 years of filings, most recently posting $2.1 billion for Q3 2025.

• Inventory Average for Q3 2025 came in at $2.1 billion, up 143.33% year-over-year; the trailing twelve-month figure through Sep 2025 was $2.1 billion (up 143.33% YoY), and the FY2025 annual result was $2.1 billion, up 143.31% from the prior year.
• Inventory Average came in at $2.1 billion for Q3 2025 at Universe Pharmaceuticals, up from $868.5 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $953.1 billion in Q3 2021 to a low of -$236022.5 in Q1 2023.
• The 5-year median for Inventory Average is $2.3 million (2022), against an average of $119.5 billion.
• Across the five-year window, Inventory Average tumbled 109.06% in 2023 and soared 563898.65% in 2024, its largest moves.
• Universe Pharmaceuticals' Inventory Average stood at $953.1 billion in 2021, then tumbled by 100.0% to $1.7 million in 2022, then sank by 109.06% to -$154051.5 in 2023, then jumped by 563898.65% to $868.5 million in 2024, then surged by 143.33% to $2.1 billion in 2025.
• The last three Inventory Average figures came in at $2.1 billion (Q3 2025), $868.5 million (Q3 2024), and $103598.0 (Q1 2024), per Business Quant data.